The verified answer
As of Oct 2026, DEPLOY verifies Galen Robotics: 1 model, 1 deployment across 1 region, $26.1M raised. 3 sources back the record.
CategorySurgical robots
Overview
Baltimore-based surgical robotics company developing the Galen ES robotic surgical assistant platform, the first cooperatively powered robotic surgical system for ear, nose, and throat (ENT) procedures. Spun out of Johns hopkins university, Galen received FDA De Novo clearance for ENT surgeries. The company uses a digital-surgery-as-a-service business model — placing robots at hospitals and charging per use rather than upfront capital purchase. Relocated from Silicon Valley to Baltimore in 2019 with state and city incentives.
Verified record
- Verified deployments
- 1 deployment on file
- Active incidents
- None on file
Key facts
CEO
Product
FDA clearance
Total fundingsee investors →
Business model
Origin
Financial stage
Galen ES regulatory milestone (primary Galen Robotics)
Surgical assistance model (primary Galen Robotics)
Data & sources
Web sources
3
3 sources backing this record.View all →
Models (1)
View all models →Galen Robotics on the deployment map
View the global map1 verified deployment across 1 region, newest verified Sep 2023. Explore where Galen Robotics's robots are operating, by place and type.
View the full Galen Robotics deployment record →
Relationships
Current leadership (1)
- Bruce Lichorowic President & CEOSEC-verified
Safety record
No incidents on record for Galen Robotics.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Galen Robotics1 deployment
Recent coverage
Galen Robotics in third-party press
Peers
41 peers across 1 segment. Every Galen Robotics competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Andromeda Surgicaldirect competitor(inferred)moderate
- Asensus Surgicaldirect competitor(inferred)moderate
- Boston Scientificdirect competitor(inferred)moderate
- Brain Navidirect competitor(inferred)moderate
- Brainlabdirect competitor(inferred)moderate
- Butterfly Networkdirect competitor(inferred)moderate
Mentioned on (3)
Registry pages whose text names Galen Robotics.
Robots and products (1)
Deployments (1)
People (1)
Financial state
- Total funding
- $26.1M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- early
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series A
$26M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 18, 2026
Added to the verified registry
- Deployment verifiedVerifiedSep 1, 2023
Galen Surgical Robot at Baltimore, MD, USA
Sources (3)
Common questions
What is Galen Robotics?
What does Galen Robotics make?
Is Galen Robotics publicly traded?
Who competes with Galen Robotics?
Who is the CEO of Galen Robotics?
How can I invest in Galen Robotics?
Where is Galen Robotics headquartered?
How much funding has Galen Robotics raised?
Who owns Galen Robotics?
Where does Galen Robotics operate robots?
How many robots has Galen Robotics deployed?
Is Galen Robotics a top robotics company?
Is Galen Robotics safe?
Methodology: Verified · 3 sources (no primary) · last reviewed 2026-10-10
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-10
Sources by quality tier
- 3
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Galen Robotics.Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
In the press
Recent coverage mentioning Galen Robotics from third-party publications. Automatically surfaced; not part of the verified registry record.
Galen robot gets FDA de novo clearance for ENT surgeries
Galen Robotics' Galen ES robotic surgical platform received FDA De Novo clearance for performing ear, nose, and throat surgeries — the first of its kind.
Galen Robotics wins FDA de novo nod for ear, nose, throat surgical robot
Galen ES Robotic System granted FDA De Novo clearance in record time. CEO Bruce Lichorowic said the company has submitted a new collaborative soft tissue surgical robot to FDA.
TEDCO Seed Funds Invest in Galen Robotics, Inc.
TEDCO (Maryland's economic engine) invested $500K seed funding in Galen Robotics, a Baltimore-based surgical robotics company.
Galen Robotics Announces Over-Subscribed $15 Million Series A
Galen Robotics closed an oversubscribed $15M Series A to advance its surgical robotics platform. Business model pivots from upfront hospital purchase to…
Machine-readable surfaces
- Markdown mirror: /companies/galen-robotics.md
- RSS feed: /companies/galen-robotics/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/97859053-8687-4b20-ba48-171158652bae
- Revision history: /companies/galen-robotics/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
Video
The Silicon Valley startup, Galen Robotics, relocated to Baltimore in 2019, thanks to incentives from both the city and state, bringing along cutting-edge techn
Bruce Lichorowic is President & CEO of Galen Robotics. He will be a panelist on the Innovation Panel “Opportunities in the Drive Towards Intelligent Surgery” at
Meet Galen VEX, one of the Australian teams competing in the International KIBO Robot Programming Challenge.
Bruce Lichorowic sat down at LSI Europe ‘23 to discuss how Galen Robotics aims to support the operating room and why they choose to join LSI Emerging Medtech Su
Bruce Lichorowic joined Ben Glenn for a studio interview at LSI USA ‘23 Emerging Medtech Summit. Galen Robotics is a digital-surgery-as-a-Service (DSaaS) combi
#GalenThePharmacyElf checks out the East Lancashire Hospitals Pharmacy Robot - December 2019. @ELHT_NHS @ReferToPharmacy
Live recording of MD&West 2021 Podcast Recording with Dave Saunders or Galen Robotics, hosted by Scott Johnson, MBA of DeviceAlliance www.devicealliance.org
Dave Saunders, CTO & Co-Founder of Galen Robotics, joins Rich Bendis on a special BioTalk before their 5/6/2022 Open House in Baltimore. RSVP to OPENHOUSE@G
This talk is part of MISSABCON 2024 Organising Secretary - Dr. Ajay Krishnan Organising Chairman - Dr. Amit C Jhala OrthoTV : Orthopaedic Surgery & Rehabilita
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Galen Robotics draws attention at the 21st percentile but verifies reality at the 1st percentile among surgical robots. Hype Gap +19.6, 16th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 1 verified deployment. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 18, 2026